Melatonin Prices, Chart, News, Graph, Monitor and Forecast

The price of melatonin in the United States for Q4 2023 reached 123,074 USD/MT in December.

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Melatonin Price in USA

  • United States: 123,074 USD/MT

The price of melatonin in the United States for Q4 2023 reached 123,074 USD/MT in December.

The latest report by IMARC Group, titled "Melatonin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of melatonin prices. This report delves into globally, presenting a detailed analysis, along with informative price chart. Through comprehensive price analysis, the report sheds light on the key factors influencing these trends. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the demand, analyzing how it impacts market dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.

Melatonin Prices Analysis:

  • China: 89,110 USD/MT
  • Germany: 90,816 USD/MT

Report Offering:

  • Monthly Updates: Annual Subscription
  • Quarterly Updates: Annual Subscription
  • Biannually Updates: Annual Subscription

The study delves into the factors affecting melatonin price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

Request For a Sample Copy of the Report: https://www.imarcgroup.com/melatonin-pricing-report/requestsample

Melatonin Price Trend- Last Quarter

The melatonin market is driven by increasing consumer awareness of sleep health and the rising prevalence of sleep disorders such as insomnia. The growing interest in natural and non-prescription sleep aids has fueled the demand for melatonin supplements. Additionally, the aging population, which is more prone to sleep disturbances, contributes to market growth. Expanding research supporting melatonin's benefits for sleep, jet lag, and overall health enhances its popularity. The rise of health and wellness trends, coupled with greater accessibility through online and retail channels, also boosts the market. Regulatory approvals and endorsements by health professionals further support the widespread adoption of melatonin products.

Melatonin Industry Analysis

The fourth quarter of 2023 saw a significant drop in melatonin prices in the North American region, which was ascribed to several factors. Primarily, there was unstable demand in the market, especially from end customers in the pharmaceutical and nutraceutical industries. Throughout the entire quarter, this low demand pattern continued. Additionally, lower manufacturing output and an excess of melatonin were factors in the price decline. In the fourth quarter of 2023, the Melatonin market in the Asia-Pacific region demonstrated a downward trend. This declining trend was attributed to a market imbalance caused by reduced demand from the pharmaceutical and nutraceutical industries, particularly evident in November.

In China, despite the increased production, the nation experienced notable price decreases attributed to sluggish demand both locally and globally. The decline in Melatonin demand in China's pharmaceutical and nutraceutical sectors was further indicated by the absence of fresh inquiries from overseas markets in the initial half of the quarter. The European melatonin market had a mixed performance in the fourth quarter of 2023. High levels of supply initially caused problems in the market, forcing domestic businesses to stockpile a lot of merchandise before the December holiday season. Price reductions during the first quarter of the quarter were made possible by a glut of melatonin on the domestic market, a decline in end-user demand, and an excess supply of the substance.

Regional Price Analysis:

  • Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
  • Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece
  • North America: United States and Canada
  • Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
  • Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco

Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145